{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T07:00:16Z","timestamp":1760425216089},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1097\/jcp.0b013e3182946586","type":"journal-article","created":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T15:27:22Z","timestamp":1371137242000},"page":"570-571","source":"Crossref","is-referenced-by-count":16,"title":["Clozapine Toxicity and Hepatitis"],"prefix":"10.1097","volume":"33","author":[{"given":"Cara A.","family":"Brown","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Summer","family":"Telio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline A.","family":"Warnock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert H.C.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-22-20210128","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00004714-200302000-00018","article-title":"Efficacy of clozapine in the treatment of atypical antipsychotic refractory schizophrenia: a pilot study.","volume":"23","author":"Narendran","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"R2-22-20210128","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/00004714-199708000-00012","article-title":"Hepatotoxicity of clozapine.","volume":"17","author":"Hummer","year":"1997","journal-title":"J Clin Psychopharmacol"},{"key":"R3-22-20210128","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00004714-200104000-00014","article-title":"Relevance of liver enzyme elevations with four different neuroleptics: a retrospective review of 7,263 treatment courses.","volume":"21","author":"Gaertner","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"R4-22-20210128","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/hup.842","article-title":"Metabolic differences between Asian and Caucasian patients on clozapine treatment.","volume":"22","author":"Subramaniam","year":"2007","journal-title":"Hum Psychopharmacol"},{"key":"R5-22-20210128","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1176\/ajp.150.6.985b","article-title":"Toxic hepatitis by clozapine treatment.","volume":"150","author":"Kellner","year":"1993","journal-title":"Am J Psychiatry"},{"key":"R6-22-20210128","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1176\/ajp.152.2.296b","article-title":"Clozapine-induced toxic hepatitis.","volume":"152","author":"Thatcher","year":"1995","journal-title":"Am J Psychiatry"},{"key":"R7-22-20210128","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/0269881105047287","article-title":"Clozapine-induced toxic hepatitis with skin rash.","volume":"19","author":"Fong","year":"2005","journal-title":"J Psychopharmacol"},{"key":"R8-22-20210128","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1445-5994.2006.01300.x","article-title":"Acute onset of ascites with clozapine-induced hepatitis.","volume":"37","author":"Luo","year":"2007","journal-title":"Intern Med J"},{"key":"R9-22-20210128","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00004850-199803000-00007","article-title":"Hepatitis, hyperglycemia, pleural effusion, eosinophilia, hematuria and proteinuria occurring early in clozapine treatment.","volume":"13","author":"Thompson","year":"1998","journal-title":"Int Clin Psychopharmacol"},{"key":"R10-22-20210128","first-page":"393","article-title":"Clozapinean atypical reaction.","volume":"45","author":"Patton","year":"2000","journal-title":"Can J Psychiatry"},{"key":"R11-22-20210128","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0016-5085(97)70054-4","article-title":"Fatal acute fulminant liver failure due to clozapine: a case report and review of clozapine-induced hepatotoxicity.","volume":"112","author":"Macfarlane","year":"1997","journal-title":"Gastroenterology"},{"key":"R12-22-20210128","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0278-5846(94)90010-8","article-title":"The side-effects of clozapine: a four year follow-up study.","volume":"18","author":"Marinkovic","year":"1994","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R13-22-20210128","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1176\/ajp.152.4.647b","article-title":"Dystonia and drug-induced hepatitis in a patient treated with clozapine.","volume":"152","author":"Worrall","year":"1995","journal-title":"Am J Psychiatry"},{"key":"R14-22-20210128","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF02326373","article-title":"Clozapine plasma level monitoring: current status.","volume":"67","author":"Cooper","year":"1996","journal-title":"Psychiatr Q"},{"key":"R15-22-20210128","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00004714-200108000-00007","article-title":"CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite steady-state concentrationin patients with schizophrenia.","volume":"21","author":"Ozdemir","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"R16-22-20210128","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/jac\/dkr159","article-title":"Hepatic safety of antibiotics used in primary care.","volume":"66","author":"Andrade","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"R17-22-20210128","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2190\/44WA-WXF7-3UHA-FDV1","article-title":"Management of marked liver enzyme increase during clozapine treatment: a case report and review of the literature.","volume":"34","author":"Erdogan","year":"2004","journal-title":"Int J Psychiatry Med"},{"key":"R18-22-20210128","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00004714-199702000-00025","article-title":"Marked liver enzyme elevations with clozapine.","volume":"17","author":"Markowitz","year":"1997","journal-title":"J Clin Psychopharmacol"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JCP.0b013e3182946586","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:01:38Z","timestamp":1620957698000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201308000-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3182946586","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}